Cdx binding determines the timing of enhancer activation in postnatal duodenum

Area of Science:

• Molecular Biology
• Genetics
• Developmental Biology

Background:

• Adenosine deaminase (ADA) expression is restricted to the duodenal villi in mammalian intestine.
• A duodenum-specific enhancer in the human ADA gene regulates this expression pattern.
• Previous studies identified PDX-1 and GATA factor binding sites essential for enhancer function.

Purpose of the Study:

• To identify and characterize additional regulatory elements and transcription factors involved in ADA duodenum-specific enhancer activity.
• To investigate the functional roles of newly identified binding sites in controlling enhancer activity and developmental timing.

Main Methods:

• Electrophoretic Mobility Shift Assays (EMSA) to confirm transcription factor binding.
• Site-directed mutagenesis of identified binding sites within the enhancer region.
• Analysis of enhancer function in transgenic mice using CAT reporter gene constructions.

Main Results:

• Identified new binding sites for Cdx factors, YY1, and NFI family members within the ADA enhancer.
• Mutations in Cdx binding sites (Cdx1/Cdx2) delayed enhancer activation by 2-3 weeks in transgenic mice.
• Mutations in YY1 binding sites also delayed enhancer activation, while NFI site mutations had no observable effect.

Conclusions:

• The ADA duodenum-specific enhancer is a complex regulatory element involving at least five transcription factor families (PDX-1, GATA, Cdx, YY1, NFI).
• Cdx and YY1 binding sites play crucial roles in regulating the developmental timing of ADA enhancer activation.
• These findings provide insights into the molecular mechanisms controlling tissue-specific gene expression in the mammalian intestine.